Pamidronate Treatment of a Patient with Opsismodysplasia and a Novel INPPL1 Variant: Efficacy, Mechanism, and Clinical Outcomes
Authors:
- Gulin TabanliGTGulin Tabanli
- Filiz HazanFHFiliz Hazan
- Gulsen OzerGOGulsen Ozer
- Ozge KopruluOKOzge Koprulu
- Ozlem NalbantogluONOzlem Nalbantoglu
- Behzat OzkanBOBehzat Ozkan
- 3 June 2025
- journal article
- Published by S. Karger AG in Molecular Syndromology
- Vol. 17 (1) , 96-100
Abstract
Introduction: Opsismodysplasia (OPS) is a rare skeletal dysplasia characterized by delayed bone maturation, distinctive skeletal deformities, and severe growth impairment. Mutations in the INPPL1 gene, particularly homozygous variants, are the primary genetic cause of this condition. While bisphosphonate therapy has shown efficacy in OPS cases with hypophosphatemic rickets, its role in cases without this complication remains unclear. Case Presentation: A 2-year-and-2-month-old girl with OPS was treated with intravenous pamidronate (0.5 mg/kg/3 months). Initial evaluations showed severe short stature and low bone mineral density (DEXA SDS: −3.16). After three courses of treatment, the patient achieved independent walking, and her DEXA SDS improved to −2.5 over 1 year. Discussion: Pamidronate is effective in treating OPS even in the absence of hypophosphatemic rickets, showing potential as a therapeutic option for this rare condition.Keywords
This publication has 10 references indexed in Scilit:
- Efficacy and safety of intravenous pamidronate infusion for treating osteoporosis in children and adolescentsAnnals of Pediatric Endocrinology & Metabolism, 2021
- Prenatal‐onset INPPL1‐related skeletal dysplasia in two unrelated families: Diagnosis and prediction of lethalityClinical Case Reports, 2021
- Novel compound heterozygous mutations in inositol polyphosphate phosphatase-like 1 in a family with severe opsismodysplasiaClinical Dysmorphology, 2016
- Opsismodysplasia: Phosphate Wasting Osteodystrophy Responds to Bisphosphonate TherapyFrontiers in Pediatrics, 2015
- Exome Sequencing Identifies INPPL1 Mutations as a Cause of OpsismodysplasiaThe American Journal of Human Genetics, 2013
- Whole-Genome Analysis Reveals that Mutations in Inositol Polyphosphate Phosphatase-like 1 Cause OpsismodysplasiaThe American Journal of Human Genetics, 2013
- SHIP2 multiple functions: A balance between a negative control of PtdIns(3,4,5)P 3 level, a positive control of PtdIns(3,4)P 2 production, and intrinsic docking propertiesJournal of Cellular Biochemistry, 2011
- Atlanto-axial segmentation defects and os odontoideum in two male siblings with opsismodysplasiaSkeletal Radiology, 2008
- The termination of PI3K signalling by SHIP1 and SHIP2 inositol 5-phosphatasesAdvances in Enzyme Regulation, 2003
- Opsismodysplasia: A new type of chondrodysplasia with predominant involvement of the bones of the hand and the vertebraeAmerican Journal of Medical Genetics, 1984